Our newest issue features informative articles on COPD, Diabetes, Mediterranean Diet, Erectile Dysfunction, and more! Click here to read more!Read More
Premier Medical Group’s Clinical Research Division is celebrating another clinical trial success with the FDA’s recent announcement on the approval of Flibanserin. Flibanserin is a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (HSDD). HSDD is the most common form of female sexual dysfunction (FSD) and occurs when there is a persistent lack...Read More
With the official opening of Premier Women’s Center for Continence & Sexual Health, women in the Hudson Valley have a dedicated medical practice specifically charged with addressing sensitive health issues in a compassionate and caring environment. The center’s providers offer a full range of treatment options in one comfortable, patient-centric facility. The center actually began...Read More
Premier Medical Group of the Hudson Valley Recognizes Urologist Dr. Daniel Katz Head of Women’s Center Offers Expertise for Stigmatized Health Conditions What is urinary incontinence? What are female pelvic floor disorders? Who do they affect? Where does one look for treatment? While the answers are quite simple, these questions, unfortunately, are rarely asked due...Read More
The path to overcoming female sexual disorder (FsD) has grown much clearer over the last decade. At Premier Women’s Center for Continence and sexual Health we now have a wide array of diagnostic tools, medications and treatment protocols with which to help our patients. By taking into account the interconnected realms that effect female sexuality,...Read More
Women do not have to resign themselves to sexual dysfunction. With the type of comprehensive treatment we provide—delivered in an environment of privacy, dignity and respect—90 percent of our patients experience improvement in their sexual health. With the plethora of ads for erectile dysfunction treatments that dominate the media, it would seem that only men...Read More
